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Combined patch-clamp and fura- measurements were performed to study the calcium release properties of Chinese hamster ovary (CHO) cells 
transfected with the rabbit skeletal muscle ryanodine receptor cDNA carried by an expression vector. Both caffeine (l-50 mM) and ryanodine 
(100 PM) induced release of calcium from intracellular stores of transformed CHO cells but not from control (non-transfected) CHO cells. The 
calcium responses to caffeine and ryanodine closely resembled those commonly observed in skeletal muscle. Repetitive applications of caffeine pro- 
duced characteristic all-or-none rises in intracellular calcium. Inositol 1,4,5trisphosphate (IPJ neither activated the ryanodine receptor channel 
nor interfered with the caffeine-elicited calcium release. These results indicate that functional calcium release channels are formed by expression 
of the ryanodine receptor cDNA. 
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1. INTRODUCTION 
The key events in excitation-contraction coupling of 
skeletal muscle comprise the membrane depolarization 
of transverse tubules (T tubules) and subsequent release 
of calcium from the terminal cisternae of the sar- 
coplasmic reticulum (SR) [ 1,2]. Calcium release from 
the SR occurs through a channel which is generally 
referred to as the ryanodine receptor, since it represents 
a high-affinity binding site for the plant alkaloid 
ryanodine. Reconstitution of the purified ryanodine 
receptor protein in planar lipid bilayers has supported 
the idea of its functioning as a calcium release channel 
[3,4]. The properties of the calcium release mechanism 
have been studied in intact muscle and in ‘skinned’ mus- 
cle fibers, where it was found that calcium release can 
be induced either depolarization, increases in the con- 
centration of free intracellular calcium [Cali (Ca- 
induced calcium release) or the pharmacological actions 
of ryanodine and caffeine (see [1,4] for review). Also, 
inositol 1,4,5trisphosphate (IP3) has been suggested to 
play a role in excitation-contraction coupling [5-71, 
possibly by activating the ryanodine receptor channel. 
However, the in vivo physiological activation of 
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calcium release by IPs in skeletal muscle is a matter of 
debate [8,9]. 
The ryanodine receptor is thought to form a homo- 
tetrameric complex (monomeric M, - 450 Ooo) with the 
characteristic ‘foot’ structure which spans the gap bet- 
ween SR and T-tubule membranes, as shown by elec- 
tron micrographs [lO,ll]. Cloning and sequence 
analysis of cDNA have revealed that the rabbit skeletal 
muscle ryanodine receptor is composed of 5037 amino 
acids with the C-terminal region which includes 4 
putative transmembrane segments, probably forming 
the calcium release channel, and the remaining portion 
apparently constituting the ‘foot’ structure [12]. It has 
also been shown that expression of the cloned cDNA in 
Chinese hamster ovary (CHO) cells yields a protein in- 
distinguishable from the ryanodine receptor in im- 
munoreactivity, molecular size and ryanodine binding 
[121. 
We have now carried out combined patch-clamp [131 
and fura- [14] experiments which show that the 
skeletal muscle ryanodine receptor expressed in CHO 
cells indeed functions as an intracellular calcium release 
channel. Thus, caffeine and ryanodine both release 
calcium from intracellular stores in a way reminiscent 
of responses observed in skeletal muscle. 
2. MATERIALS AND METHODS 
Clones of CHO cells (C73 11 and C798) that were transformed with 
the plasmid pRRS7 to express the rabbit skeletal muscle ryanodine 
receptor were obtained as described previously [12]. An additional 
clone (Cl1727) was isolated by transfecting CHO cells with the 
plasmid pRRSl1, in which the in-frame ATG triplet located 33 base 
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pairs upstream from the translational initiation codon of pRRS7 was 
deleted. pRRSl1 was constructed as follows (see [12] for cDNA clones 
and nucleotide numbers identifying restriction endonuclease sites). 
pRR705 was digested with SmaI, ligated with the Hind111 linker 
dACAAGCTTGT and cleaved with Hind111 and SphI. The resulting 
0.36-kilobase-pair (kb) HindIII(linker)/SphI(335 fragment, the 
SphI(335)/BgRI (1855) fragment from pRR256 and the Bg/II(1855) 
/SucI(3629) fragment from pRR229 were ligated with the 5.6-kb Sac1 
(3629)/HindIII(vector) fragment from pRRSlb to yield pRRSlc. The 
6.5-kb HindIII(vector)/XhoI(6467) fragment from pRRSlc, the 
XhoI(6467)/&mHI(lO983) fragment from pRRS2M and the 4.3-kb 
BumHI(10983)/XbaI(vector) fragment from pRRS3 were ligated with 
the XbaI/NindIII fragment from pSP64 (Promega) to yield pRRSl0. 
The 15.3-kb Hind111 fragment containing the entire protein-coding 
sequence from pRRSl0 was cloned into theHind site of pKNH [15] 
to yield pRRSl1. CHO cells were transfected with fit&cleaved 
pRRSl1 and G418-resistant clones were screened by RNA blotting 
analysis as in [12]. Expression of the ryanodine receptor in Cl 1727 
cells was confirmed by immunoblotting analysis and [‘Hlryanodine 
binding assay as in [12]; Scatchard analysis showed that membrane 
preparations from Cl1727 cells had a ryanodine binding capacity 
(B,,,) of 3.3 pmol/mg protein and a binding affinity (Kd) of 20 nM. 
Most of the calcium release xperiments were performed with clone 
C73 11. The percentage of cells that responded to caffeine gradually 
decreased over 2-3 weeks in the course of cell growth. Therefore, a 
new batch of frozen cells was cultured every two weeks. Round cells 
with refractile inclusions were selected for the experiments. Normal 
and transformed CHO cells were plated on cover slips and cultured at 
37°C and 10% CO;? in a medium supplemented with fetal calf serum 
(IO%), glutamine (2 mM), penicillin (0.06 mg/ml), streptomycin (0.11 
mg/ml) and Na-pyruvate (1 mM). Experiments were performed at 
23-26°C in a saline solution containing (in mM):NaCl 140, KC1 2.8, 
CaClz 1, M&l* 2, glucose 12, Hepes-NaOH 10, pH 7.2. Calcium 
measurements and calibration procedures were performed as describ- 
ed previously [14,16,17]. Briefly, fura- fluorescence was excited at 
360 and 390 nm and [Cal, was calculated from the fluorescence ratio. 
Data points were sampled at 500 ms intervals with a computer 
calculating [Cal, on-line. Two methods of loading the calcium in- 
dicator dye fura- were used: (1) Ester-loading: cells were incubated 
at room temperature in standard saline with fura-2-AM (l-2pM) for 
30 min after which they were washed and placed in an incubator for 
15 min at 37°C. (2) Pipette-loading: fura- pentapotassium salt (100 
PM) was added to the internal solution used for filling patch-pipettes. 
The pipette filling solution comprised (in mM): K-glutamate 145, 
NaCl 8, MgCls 1, Mg-ATP 0.5, Hepes-KOH 10, pH 7.2. Drug ap- 
plications were made by pressure-ejection from a pipette containing 
extracellular saline and the compound under investigation. Caffeine 
(Sigma) was used at concentrations of l-50 mM, ryanodine (HPLC 
Grade, Wako Ltd., Japan) at 100/M, and procaine (Sigma) at l-10 
mM. IP3 (Amersham) at 1OpM or GTPrS (kindly provided by Dr F. 
Eckstein, Gottingen, FRG) at 100pM was added to the intracellular 
solution. 
3. RESULTS 
The first series of experiments was designed to find 
out whether CHO cells transformed to express the rab- 
bit skeletal muscle ryanodine receptor have functional 
calcium release channels. Fig.lA illustrates typical 
changes in [Cali in response to a brief application of 
caffeine (10 mM). Similar responses to caffeine (lo-50 
mM) were observed in the 14 out of 24 cells tested (clone 
C73 11). Cells from clone C 11727 were similarly respon- 
sive (7 out of 11 cells), whereas cells from clone C798 
responded less frequently (8 out of 29 cells). In non- 
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transfected CHO cells application of 10 mM caffeine 
never elicited measurable calcium changes (19 cells). 
Caffeine at 1 mM yielded indistinguishable changes in 
[Cali but the percentage of responsive cells was slightly 
lower (5 out of 11 cells from clone C7311). Subsequent 
experiments were therefore carried out at a caffeine 
concentration of 10 mM. 
The time course of [Cali responses to caffeine was 
relatively uniform, with the rising phase reaching a 
peak within 2-6 s. The peak amplitudes of the responses 
were unrelated to the concentration of caffeine used 
and averaged 0.69 f 0.24 pM (mean f SD, n = 24, 
excluding unresponsive cells). The delay between ap- 
plication of caffeine and onset of the [Cali response 
showed some degree of variability. In most cases the 
[Cali response occured within 2-10 s but in some cells it 
took more than 60 s before [Cali started to rise. Follow- 
ing the rise, [Cali remained elevated for lo-40 s and 
then declined precipitously regardless of whether the 
caffeine application continued or had been stopped. 
The changes in [Cali were clearly due to release of 
calcium from intracellular stores, since similar 
responses were observed after removing calcium from 
the bath solution (fig.lB). Further evidence for this 
conclusion was provided by experiments in which caf- 
feine was applied repeatedly to test for possible refilling 
of the internal calcium pools (fig.lC). Repetitive 
responses were elicited by stimulation at 1 min inter- 
vals. In this case, however, after 4 applications the fifth 
one was ineffective in inducing calcium release. Subse- 
quent applications produced either normal-sized 
responses or failures, presumably depending on the fill- 
ing state of the internal stores. The responses eemed to 
be ‘all-or-none’ and a similar behaviour was observed 
in a number of cells. This pattern may have important 
implications for the regulation of the calcium release 
mechanism (see section 4). Some cells, however, re- 
mained refractory to further applications of caffeine 
once the stores had been depleted. 
Ryanodine is another substance known to release 
calcium from skeletal muscle SR [ 181 and it proved to 
do so in transformed CHO cells. We observed quite 
variable responses upon application of ryanodine (100 
,uM). Examples of such experiments are illustrated in 
fig.2A. Ryanodine responses were usually very sluggish 
and outlasted the actual drug application time. Slow 
and multiphasic calcium transients like those in the 
middle trace of fig.2A were often superimposed on a 
slower wave of [Cali. The rather slow onset of the 
response probably cannot be ascribed to ryanodine not 
reaching its site of action, since applying ryanodine in- 
tracellularly through patch-pipettes yielded similarly 
slow and long-lasting changes in [Cali (not illustrated). 
We have tested 3 additional ways of activating the 
calcium release mechanism, which all proved to be inef- 
fective. (1) We were unable to induce changes in [Cali 
following depolarization of the plasma membrane of 
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Fig.1. Caffeine-induced release of calcium from CHO cells trans- 
formed to express the ryanodine receptor. (A) Typical response of a 
fura-2-AM-loaded cell (clone C7311) to caffeine (10 mM). Applica- 
tion of caffeine was performed by pressure-ejection from a wide- 
tipped micropipette for the time indicated by the bar. (B) Experimen- 
tal conditions as in A, except hat the second application of caffeine 
was performed after replacing the normal saline by one containing 
nominally zero calcium (as indicated in the trace). The application 
pipette contained 10 mM caffeine in calcium-free saline (for both ap- 
plications). (C) Experimental conditions as in A, except that the cell 
was repeatedly subjected to caffeine pulses of 10 s duration at 1 min 
intervals (as indicated in the trace). The baselines are indicated by 
broken lines. 
transformed CHO cells under voltage clamp. (2) Perfu- 
sion of CHO cells with IP3, which has been invoked as 
a candidate for activating calcium release from SR 
[5,6], did not stimulate the caffeine-sensitive calcium 
release mechanism. We were surprised to learn that IP3, 
which causes calcium release in most cell types, induced 
only very small changes in [Cali in transformed CHO 
cells. In no case did we see calcium release as dramatic 
as that found with caffeine. Fig.2B shows an experi- 
ment in which we first induced calcium release by caf- 
feine to make sure that the cell used was responsive, and 
then the cell was dialysed with a patch-pipette contain- 
ing 10 PM IP,. After establishment of the whole-cell 
configuration, IP3 induced a small calcium transient 
and subsequent applications of caffeine caused con- 
siderably larger changes in [Cali despite the presence of 
ryanodine ’ 120s ’ 
OJ . . . . ..~.~~~.__....._~~___.._.......~~~~~~.~~. 
1 
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Fig.2. Changes in [Cal, induced by ryanodine, caffeine and IP,. In all 
cases, transformed CHO cells (clone C7311) were used and periods of 
drug application are indicated by bars. (A) Examples of responses of 
fura-2-AM-loaded cells to ryanodine (100 ,uM). Application of 
ryanodine was performed by pressure-ejection from a wide-tipped 
micropipette. Note the different time scales. (B) Effects of IPI 
(10 PM) and caffeine (10 mM). The cell was loaded with fura-2-AM 
and tested for caffeine response (1). Then a whole-cell recording con- 
figuration was established (arrow) with a patch-pipette containing 
fura- (100 PM) and IPS (10 PM). Note the small calcium transient in- 
duced by IPI (2). Subsequent applications of caffeine (3 and 4) pro- 
duced large changes in [Cal,. The trace is interrupted during the time 
of approaching the cell with the patch-pipette. The baselines are 
marked by broken lines. 
IP3. (3) Perfusing CHO cells with GTPyS (100 PM) to 
activate G proteins gave results similar to those obtain- 
ed with IP3, i.e. there was no or very little calcium 
releasing activity, the latter being induced probably by 
liberation of IP3. Caffeine was still able to release a 
large amount of calcium from internal stores in cells 
perfused with GTPyS (data not shown). 
Further attempts to characterize the expressed 
ryanodine receptor, particularly with respect to phar- 
macological blocking agents such as dantrolene or 
ruthenium red, were precluded by their interference 
with fura- fluorescence. Unfortunately, CHO cells 
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also lack calcium-activated potassium or chloride chan- 
nels, which could have been used as an alternative way 
of monitoring changes in [Cali. Procaine, another 
blocker of calcium release in skeletal muscle [l], was 
not very effective in suppressing caffeine-induced 
calcium release. Procaine at 1 mM showed no obvious 
effect on caffeine responses, although very high con- 
centrations (10 mM) were effective in most cells. 
4. DISCUSSION 
The present results unequivocally show that the 
ryanodine receptor of skeletal muscle functions as a 
calcium release channel when expressed in CHO cells by 
transformation with its cDNA. The pharmacological 
activation of the calcium release mechanism is similar 
to that observed in intact skeletal muscle fibres [19], as 
witnessed by the changes in [Cali induced by caffeine 
and ryanodine. As in muscle cells, caffeine causes a 
prompt increase in [Cali that rapidly fades as the drug 
is removed. In contrast, ryanodine produces a slower 
but sustained increase in [Cali that persists long after 
drug removal, again in agreement with studies on the 
native tissue. This behavior of ryanodine is consistent 
with the observation that it induces a persistent, but 
partial activation of the ryanodine receptor channel 
reconstituted in planar lipid bilayers [20,21]. 
Multiple applications of caffeine at regular intervals 
produced an interesting response pattern in many of the 
cells tested. The first few changes in [Cali were quite 
uniform in shape and amplitude, whereas subsequent 
applications resulted in either complete failures or 
normal-sized [Cali responses, rather than in gradual 
decreases in the amplitude of the responses. This 
behaviour might be interpreted by a mechanism in 
which the activation of the calcium release channel by 
caffeine is dependent on the filling state of the in- 
tracellular stores [ 11. In such a model ineffective stimuli 
should not lead to the opening of the calcium release 
channel due to a low filling state of the intracellular 
stores. However, refilling would continue so that the 
stores are ready for release at the time of the next 
stimulus. The hypothesis that a calcium release channel 
is sensitive to the intrastore calcium concentration has 
been explored in theoretical models for IPS-induced 
calcium release [22] and for Ca-induced calcium release 
from heart SR [23]. 
Our finding that in transformed CHO cells IP3 hardly 
increases [Cali does not support the hypothesis that IP3 
is an activator of the ryanodine receptor channel. The 
fact that caffeine, applied after dialysing cells with IP3, 
can elicit a large calcium signal suggests that the 
caffeine-sensitive calcium pool in these cells is different 
from and larger than the IP3-sensitive pool. It is known 
that different fractions of the endoplasmic reticulum 
show different calcium releasing activities in response 
to IP3 [24], and it may be suggested that the expressed 
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ryanodine receptor is incorporated into parts of the en- 
doplasmic reticulum that are insensitive to IP3. 
Depolarization and charge movement within the T- 
tubular membrane are thought to be triggering steps for 
calcium release in skeletal muscle [25], but we found no 
depolarization-induced changes in [Cali. This implies 
that the voltage-sensing link between plasma membrane 
and intracellular stores is missing in CHO cells, where 
no such voltage sensor is expected. It has been suggested 
that in the triads of skeletal muscle this link is provided 
by the dihydropyridine receptor [26-281. An alternative 
explanation for the ineffectiveness of depolarization in 
activating the calcium release mechanism could be that 
CHO cells lack the specialized morphological organiza- 
tion at the triads of skeletal muscle and that such an 
organization is required for voltage-induced activation 
of the ryanodine receptor channel. 
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